Evidence map›Paper›PMID 26973453›Full record

ArticleFrontiers in neuroscience2016

Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis.

Rosa López-Hidalgo, Raul Ballestín, Jessica Vega, José M Blasco-Ibáñez, Carlos Crespo, Javier Gilabert-Juan, Juan Nácher, Emilio Varea

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rosa López-HidalgoNeurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department, Universitat de ValènciaValència, Spain; Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina (BIOTECMED), Universitat de ValènciaValència, Spain.
Raul BallestínNeurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department, Universitat de ValènciaValència, Spain; Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina (BIOTECMED), Universitat de ValènciaValència, Spain.
Jessica VegaNeurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department, Universitat de ValènciaValència, Spain; Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina (BIOTECMED), Universitat de ValènciaValència, Spain.
José M Blasco-IbáñezNeurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department, Universitat de ValènciaValència, Spain; Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina (BIOTECMED), Universitat de ValènciaValència, Spain.
Carlos CrespoNeurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department, Universitat de ValènciaValència, Spain; Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina (BIOTECMED), Universitat de ValènciaValència, Spain.
Javier Gilabert-JuanNeurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department, Universitat de ValènciaValència, Spain; Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina (BIOTECMED), Universitat de ValènciaValència, Spain; Fundación Investigación Hospital Clínico de Valencia, INCLIVAValència, Spain; CIBERSAM, Spanish National Network for Research in Mental HealthValència, Spain; Genetics Department, CIBERSAM, Universitat de ValènciaValència, Spain.
Juan NácherNeurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department, Universitat de ValènciaValència, Spain; Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina (BIOTECMED), Universitat de ValènciaValència, Spain; Fundación Investigación Hospital Clínico de Valencia, INCLIVAValència, Spain; CIBERSAM, Spanish National Network for Research in Mental HealthValència, Spain; Genetics Department, CIBERSAM, Universitat de ValènciaValència, Spain.
Emilio VareaNeurobiology Unit and Program in Basic and Applied Neurosciences, Cell Biology Department, Universitat de ValènciaValència, Spain; Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina (BIOTECMED), Universitat de ValènciaValència, Spain.
Universitat de València · ESSpanish Clinical Research Network · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Down syndrome (DS) is caused by the presence of an extra copy of the chromosome 21 and it is the most common aneuploidy producing intellectual disability. Neural mechanisms underlying this alteration may include defects in the formation of neuronal networks, information processing and brain plasticity. The murine model for DS, Ts65Dn, presents reduced adult neurogenesis. This reduction has been suggested to underlie the hypocellularity of the hippocampus as well as the deficit in olfactory learning in the Ts65Dn mice. Similar alterations have also been observed in individuals with DS. To determine whether the impairment in adult neurogenesis is, in fact, responsible for the hypocellularity in the hippocampus and physiology of the olfactory bulb, we have analyzed cell proliferation and neuronal maturation in the two major adult neurogenic niches in the Ts656Dn mice: the subgranular zone (SGZ) of the hippocampus and the subventricular zone (SVZ). Additionally, we carried out a study to determine the survival rate and phenotypic fate of newly generated cells in both regions, injecting 5'BrdU and sacrificing the mice 21 days later, and analyzing the number and phenotype of the remaining 5'BrdU-positive cells. We observed a reduction in the number of proliferating (Ki67 positive) cells and immature (doublecortin positive) neurons in the subgranular and SVZ of Ts65Dn mice, but we did not observe changes in the number of surviving cells or in their phenotype. These data correlated with a lower number of apoptotic cells (cleaved caspase 3 positive) in Ts65Dn. We conclude that although adult Ts65Dn mice have a lower number of proliferating cells, it is compensated by a lower level of cell death. This higher survival rate in Ts65Dn produces a final number of mature cells similar to controls. Therefore, the reduction of adult neurogenesis cannot be held responsible for the neuronal hypocellularity in the hippocampus or for the olfactory learning deficit of Ts65Dn mice.

Indexed as

adult neurogenesisdoublecortindown syndromehippocampusKi67olfactory bulbTs65Dn mice

Identifiers

PMID26973453
PMCPMC4773601
OpenAlexW2326550475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.